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t~onal factors (smaller minimal lumen diameter, longer stent length, and the presence of 
diabetes), which had clinically moderate and statistically significant effects. This sug- 
gests that patients at moderate to high risk of restenosis benefit strongly from sirolimus- 
coated stents. 
OddsRatio P-Value 
Predictors of Target Lesion Revasculariration 
Treatment (control vs. sirollmus-elutmg stent) 5.97 0.0001 
Stent Length (per mm) 1.04 0.0003 
Post-Procedure Minimal Lumen Diameter (per mm) 0.37 0.0005 
Canadian Cardiovascular Society Class III/IV 1.75 0.012 
Prior Coronary Bypass Graft Surgery 2.15 0.014 
Diabetes 1.64 0.030 
1.431, p<O.O03). Conclusion: In addition to its demonstrated prognostic value for short- 
term outcomes after PCI, the present data suggest that an elevated baseline CRP is an 
equally powerful predictor of outcomes at one year following PCI. 
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813-2 Inflammatory Response After Intervention as Assessed 
by Serial C-Reactive Protein Measurements Correlates 
With Restenosis in Patients Treated With Coronary 
Stenting 
Alban Dibra. Julinda Mehilli, Sigmund Braun, Adnan Kastrati, Josef Dirschinger, Maltin 
Hadamitzki. Albert Schomig, Deutsches Herzzentrum Muenchen, Muenchen, Germany, 
Med. Klinik rechts der Isar, Muenchen. Germany 
Contradictory results have been reported about the prognostic value of inflammation 
markers for restenosis after coronary stenting (CS). We have previously found no corre- 
lation between baseline C-reactive protein (CRP) levels and in-stent restenosis. We stud- 
ied the correlation between inflammatory response to the intervention as measured by 
the change in CRP levels after CS and restenosis. We included 1,955 consecutwe pts 
with stable or unstable angina treated with CS. CRP levels were measured before and 
l&24,48 and 72 hours after CS by a high sensitivity assay. The difference (?) between 
peak CRP values after CS and CRP values before CS was calculated. Pts were grouped 
into tertiles according to ‘! CRP values. Angiographic restenosis was defined as a diame- 
ter stenosis 250% at 6.month follow-up angiography. Target vessel revascularizatlon 
(TVR) was performed in the presence of angiographic restenosis and symptoms or signs 
of ischemia. Although no relationship was found between CRP values at baseline and 
angiographic restenosis (P=O.32), a strong correlation was observed between ? CRP 
values and angiographic and clinical restenosis (P=O.O05 and PzO.013, respectively) 
(Figure). The correlation remained significant after adjusting for other covariates. 
Conclusion: The grade of inflammatory response after stent implantation as assessed 
by the difference in CRP levels before and after intervention, is a strong predictor of both 
angiographic and clinical restenosis. 
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813-3 Predictors of Clinical and Angiographic Restenosis in 
the Sirolimus-Eluting Bx VELOCITY Stent Trial 
Laura Mauri, Jeffrey J. Popma, Peter J. Fitzgerald, Martm B. Leon, Jeffrey W. Moses, 
David R. Holmes, Richard E. Kuntz, Brigham&Women’s Hospital, Boston. MA, Lenox 
Hill Hospital, New York, NY 
Background: The SIRIUS trial randomwad 1,101 patients and demonstrated superionty 
of the sirolimus-eluting Bx VELOCITY stent cwer the standard Bx VELOCITY stent in the 
prevention of restenosis in de ROW coronary lesions. We investigated whether classical 
predictors of restenosis remain important in the presence of sirolimus-eluting stents. 
Methods Multivariable logistic regression models were constructed to predict target 
lesion revascularization (TLR, repeat percutaneous intervention of the target lesion or 
bypass surgery of the target vessel at 270 days) and binary angiographic restenosis 
(BAR, t 50% diameter stenosis at 6 months). Predictors were chosen from selected 
baseline clinical and anglographic characteristics by a stepwise selection procedure. 
Results The mean reference vessel diameter was 2.60+0.47mm. lesion length 
14.4*5.6mm, and diabetes prevalence 26.4%. TLR rates were 3.9% (21/533, sirolimus- 
eluting) vs. 16.6% (671531, control), pcO.001, and BAR 3.2% (111346) vs. 35.4%(125/ 
353), p<O.OOl. Predictors of TLR and BAR are shown in the table below. Conclusion: 
The strongest predictor of restenosis was treatment aswgnment, followed by conven- 
Predictors of Binary Angiographic Restenosis Odds Ratio P-Value 
Treatment (control vs. sirolimus-eluting stent) 22.61 0.0001 
Diabetes 2.46 0.0001 
Stent Length (per mm) 1.04 0.0006 
Prior Coronary Bypass Graft Surgery 2.64 0.003 
Pre-Procedure Minimal Lumen Diameter (per mm) 0.50 0.027 
Post-Procedure Diameter Stenosis 1.03 0.032 
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813-4 Intravascular Ultrasound Predictors of Late Recurrence 
After Stent Implantation in Small Coronary Arteries 
loannis lakovou, George Dangas, Roxana Mehran, Gary S. Mintz, Alexandra J. Lansky. 
Milena G. AdamIan, Makoto HIrose. Yoshio Kobayashi, lssam Moussa, Gregg W. Stone, 
Jeffrey W. Moses, Martin B. Leon, Cardiovascular Research Foundation, New York, NY 
Introduction. We sought to determine predictors of late recurrence after intravascular 
ultrasound (IVUS)-guided stent implantation in small coronary arteries. 
Methods. We Identified 1457 consecutive patients who underwent 1514 IVUS-guided 
small vessel stenting procedures in 1637 coronary lesions with an angiographlc refer- 
ence vessel diameter <2.75mm. Patients were divided in two groups based on the final 
IVUS lumen area:q6mn+ (n=991, group I) and >6mm2 (n=466, group II). 
Results. Baseline patlent characteristics were similar between the 2 groups. Group I had 
higher target lesion revascularization (TLR) compared to Group II pattents (20.3%~~. 
14.9% p=O.O4). TLR decreased wth increasing percent stent expansion (% Expansion= 
Final Lumen CSAI [Proximal Lumen CSA + Distal Lumen CSAY 2) (Figure). Stent over- 
expansion, defined as percent expanwn >90%, occurred in 33.5% of the procedures. By 
multivarlate analysts a smaller IVUS final lumen CSA (under 6mrr?). diabetes, and 
smaller angiographlc reference vessel diameter were independent predictors of l-year 
TLR. 
Conclusions. Despite frequent stent overexpansion, a final lumen area >6.0mm? was 
associated with a reduction in TLR. Therefore, there does not appear to be any “resteno- 
sis-related downside” to aggressive stent implantation strategies in small vessels. To the 
contrary, IVUS should be used to maximize final lumen dimensions to minimize clinical 
restenosis. 
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